Octagon Capital Advisors’s Immunovant IMVT Stock Holding History

Octagon Capital Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$8.83M	Hold
2023 Q4	$11.5M	Buy
2023 Q3	–	Hold
2022 Q4	–	Sell
2022 Q3	$3.23M	Hold
2022 Q2	$2.26M	Sell
2022 Q1	$8.13M	Buy
2021 Q4	$4.88M	Buy